These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7549250)

  • 21. [Prevalence of hepatitis caused by A, B and D virus in children].
    Ruiz Moreno M; García Aguado J; Carreño García V; Alvarez Sala L; Rincón Víctor P; López-Linares del Prado M; Bas Pérez C
    An Esp Pediatr; 1988 Nov; 29(5):357-62. PubMed ID: 3232891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 2001 serological survey in the Czech Republic--viral hepatitis.
    Nemecek V; Cástková J; Fritz P; Linhartová A; Svandová E; Srámová H; Kríz B
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S54-61. PubMed ID: 15080261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
    Thierfelder W; Meisel H; Schreier E; Dortschy R
    Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroprevalence of viral hepatitis B in the city of Mahajanga, Madagascar in 1999].
    Migliani R; Rakoto Andrianarivelo M; Rousset D; Rabarijaona L; Randrianarisoa P; Roux JF
    Med Trop (Mars); 2000; 60(2):146-50. PubMed ID: 11100440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy.
    Quaglio G; Ramadani N; Pattaro C; Cami A; Dentico P; Volpe A; Pellizzer G; Berisha A; Smacchia C; Figliomeni M; Schinaia N; Rezza G; Putoto G
    J Med Virol; 2008 May; 80(5):833-40. PubMed ID: 18360897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.
    Viana S; Paraná R; Moreira RC; Compri AP; Macedo V
    Am J Trop Med Hyg; 2005 Oct; 73(4):808-14. PubMed ID: 16222030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
    Joshi N; Yr NK; Kumar A
    Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua.
    Perez OM; Morales W; Paniagua M; Strannegard O
    Am J Trop Med Hyg; 1996 Jul; 55(1):17-21. PubMed ID: 8702016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis A, B, and C in an occupational center for the mentally handicapped].
    Arnedo A; Latorre MD; Pac MR; Safont L; Guillén F; Aguinaga I
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):370-3. PubMed ID: 9835153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.
    Dal-Ré R; García-Corbeira P; García-de-Lomas J
    J Med Virol; 2000 Apr; 60(4):363-6. PubMed ID: 10686017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serological markers for hepatitis A, B and C in Madagascar. First investigation in a rural area].
    Morvan JM; Boisier P; Andrianimanana D; Razainirina J; Rakoto-Andrianarivelo M; Roux JF
    Bull Soc Pathol Exot; 1994; 87(3):138-42. PubMed ID: 7827511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiologic features of viral hepatitis in Fujian].
    Li L; He J; Zhao L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):89-92. PubMed ID: 10322717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral hepatitis in a multi-ethnic neighborhood in the Netherlands: results of a community-based study in a low prevalence country.
    Veldhuijzen IK; van Driel HF; Vos D; de Zwart O; van Doornum GJ; de Man RA; Richardus JH
    Int J Infect Dis; 2009 Jan; 13(1):e9-e13. PubMed ID: 18678518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone.
    Hodges M; Sanders E; Aitken C
    West Afr J Med; 1998; 17(1):36-7. PubMed ID: 9643158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity].
    Iashina TL; Favorov MO; Shakhgil'dian IV; Firsova SN; Eraliev AE; Zhukova LD; Reznichenko RG
    Vopr Virusol; 1992; 37(4):194-6. PubMed ID: 1471341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.